跳至主要内容
临床试验/ITMCTR2024000145
ITMCTR2024000145尚未招募2 期

Study on the clinical efficacy of Shi-Dan-Ke-Li in the treatment of chronic atrophic gastritis

Affiliated Hospital of Integrated Traditional Chinese and Western Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • 1) Meet the western medical diagnostic criteria for CAG (OLGA/OLGIM stage II and above).
  • 2) Conforms to the Chinese medicine diagnosis of CAG of the weak spleen and stomach type (spleen and stomach cold deficiency syndrome).
  • 3) Hp negative (at least one of C13 or C14 respiratory test is required)
  • 4) Age 18-70 (including 18 and 70 years old), gender is not limited.
  • 5) Voluntarily participate in this clinical trial, give informed consent and sign the informed consent form.

排除标准

  • 1 Pregnant and lactating women
  • 2 Endoscopy suggests gastric cancer and patients with pathologically confirmed gastric cancer, high-grade intraepithelial neoplasia, and severe heterogeneous hyperplasia.
  • 3 Endoscopy suggests peptic ulcer patients.
  • 4 Patients with poor adherence to medical advice or allergy to the drug.
  • 5 Patients who cannot tolerate endoscopy
  • 6 Patients with serious mental disorders who are unable to co-operate.
  • 7 Patients with abnormalities in liver and kidney function and coagulation.
  • 8Patients participating in another clinical study at the same time.

研究者

发起方
Affiliated Hospital of Integrated Traditional Chinese and Western Medicine

相似试验